Analyst Ratings for AN2 Therapeutics (ANTX)
ANTX Rating Summary
ANTX Price Target Summary
- Highest: $9.00 (Leerink)
- Lowest: $9.00 (Leerink)
- Average: $9.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.00 (+82.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$9.00 (+82.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | Guggenheim | Brad Canino | New Coverage | Buy (N/A) |
9.00 (N/A) |
4.67 (4.93) |
5.57% | Details |
| 5/14/2026 | Leerink | Joseph Schwartz | Upgrade | Outperform (Market Perform) |
9.00 (N/A) |
4.31 (4.93) |
14.39% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
